COMP <GO>
CGON vs UNH // DIVIDEND YIELD & FCF PAYOUT SAFETY
CG Oncology Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CGON 3
— UNH 9
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: UNH
LAST: $64.06 (+3.39%) • MKT CAP: $5.49B
dividend-safety
0.00%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
dividend-safety
2.29%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGON VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CGON | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.80% | 12.38% | -33.18 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.35% | 6.25% | -8.60 | UNH | /fcf-yield <GO> |
| Operating Margin | -12.10% | 5.32% | -17.42 | UNH | /operating-margins <GO> |
| Net Profit Margin | -10.20% | 3.53% | -13.73 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | 3.33% | +5.47 | CGON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.09 | +22.91 | CGON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 55.1 | -13.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.33 | +0.74 | CGON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 17.7x | +2.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.49B | $359.43B | -$353.94B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CGON REV | UNH REV | CGON GROSS % | UNH GROSS % | CGON FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $534.2M | $447.57B | — | 88.7% | -$132.5M | $16.07B |
| FY 2024 | $321.1M | $400.28B | — | 88.3% | -$78.9M | $20.70B |
| FY 2023 | $155.3M | $371.62B | — | 89.6% | -$45.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CGON // BETA 1.07
UNH // BETA 0.33